Comparison of ribosome-inactivating proteins in the induction of apoptosis

Toxicology Letters
J M WilliamsC M Taylor

Abstract

The aim of this study was to evaluate the ability of verocytotoxin-1 (VT1), VT1 B chain alone, ricin and a hybrid toxin (RASTA2) consisting of ricin A chain linked to VT1 B chain to inhibit protein synthesis and to induce apoptosis. The lethal effects of the toxins were compared using vero cells (originating from green African monkey kidney tissue). As previously described cell death occurred through apoptosis which was quantified using the diphenylamine assay. DNA fragmentation was seen with VT1 at 10 pg/ml but there was no effect with B chain alone. Fragmentation with ricin was seen at 10 ng/ml and with RASTA2 at 1 ng/ml. Protein synthesis inhibition was measured by [(35)S]methionine incorporation. VT1 had an IC50 of 0.0024 ng/ml, B chain alone was ineffective at inhibiting protein synthesis. Ricin had an IC50 of 0.39 ng/ml and RASTA2 of 1.7 ng/ml. In vero cells the B chain of these toxins does not participate in cell killing.

Citations

Jul 9, 2008·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Claudia SilbersteinCristina Ibarra
Feb 19, 2008·Archives of Pharmacal Research·Chang Joo OhJeen-Woo Park
Oct 6, 1999·Current Opinion in Immunology·R J Kreitman
Dec 22, 2009·Nature Reviews. Microbiology·Ludger Johannes, Winfried Römer
Mar 30, 2001·European Journal of Biochemistry·N OlmoM A Lizarbe
Jun 2, 1998·Kidney International·T TaguchiJ Fujimoto
Apr 14, 1999·Kidney International·C M TaylorP E Rose
Feb 21, 2002·Infection and Immunity·Paola MarcatoGlen D Armstrong
Jun 24, 2003·Infection and Immunity·Alejandra V E CapozzoMarina S Palermo
May 5, 2001·Annual Review of Plant Physiology and Plant Molecular Biology·Kirsten Nielsen, Rebecca S Boston
Apr 6, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Kazuo NittaMasahiro Hosono
Apr 7, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Robert J Kreitman
Oct 29, 2008·Evidence-based Complementary and Alternative Medicine : ECAM·V RamnathR Kuttan
Dec 13, 2005·FEBS Letters·Flor García-MayoralAlvaro Martínez del Pozo
Dec 1, 2009·Biochemical Pharmacology·Seoung Woo ShinJeen-Woo Park
Dec 22, 2007·Biochemical and Biophysical Research Communications·Seoung Woo ShinJeen-Woo Park
Apr 15, 2006·Photochemistry and Photobiology·Maria Teresa Tarragó-TraniBrian Storrie
Sep 11, 2004·Biochemical and Biophysical Research Communications·Shaker AbuharbeidAchim Aigner
Jan 14, 2012·Free Radical Research·Su Jin KohJeen-Woo Park
Nov 4, 2000·Expert Opinion on Investigational Drugs·V Pasechnik
Mar 17, 2004·The Journal of Toxicological Sciences·Yohei MiyamotoA Meguid El Nahas
Mar 2, 1999·Protein Expression and Purification·P C Sehnke, R J Ferl
May 15, 2009·Free Radical Biology & Medicine·Jean Kyoung Tak, Jeen-Woo Park
Apr 11, 2007·Advances in Cancer Research·Rosalia RabinovskyEitan Yefenof
May 23, 2007·Free Radical Research·Chang Joo OhJeen-Woo Park
Dec 24, 1998·Toxicologic Pathology·M A Davis, D H Ryan
Aug 29, 2003·The Journal of Biological Chemistry·Cecile TétaudJoëlle Wiels
May 23, 2002·FEBS Letters·T-A M YamamotoA Tunnacliffe
Feb 17, 2001·Journal of Cellular Biochemistry·N KiyokawaJ Fujimoto
Mar 5, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Maurizio BrigottiSimonetta Sperti
Jun 21, 2019·Toxins·Natalia Sowa-RogozińskaMonika Słomińska-Wojewódzka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis